Nouvelle déclaration d'incident
No de la demande: 2013-3385
Numéro de référence du titulaire d'homologation: PROSAR Case#:1-33674060
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Canada Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez l'humain
Pays: CANADA
État: ONTARIO
ARLA No d'homologation 28821 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: CRUISER MAXX BEANS SEED TREATMENT
ARLA No d'homologation 30438 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: VIBRANCE 500FS SEED TREATMENT
Oui
Inconnu
Site: Agricultural-Outdoor/Agricole-extérieur
Specify Type: Soybeans
Inconnu
Personne affectée
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Non
Inconnu
Application
Inconnu
Peau
>15 min <=2 hrs / >15 min <=2 h
Unknown / Inconnu
1-33674060 - The reporter indicated that he was exposed to treated soybean seeds which had been treated with the active ingredients thiamethoxam, metalaxyl-m, Fludioxonil and sedaxane. The reporter indicated that four days prior to initial contact with the registrant he was pouring the seeds in a spreader for a period of about one hour and during that time he was not wearing gloves. The reporter's hands turned blue during the exposure and afterwards he washed his hands for a minute or two. That night his face was red and felt like it was burning. The next morning one side of his face was swollen and he felt like he had the flu. He went to the ER that same night where they thought he might have been stung by an insect and he was treated with antibiotics. The following day, the reporter still felt like he had the flu and he went to his doctor for some new swelling that had developed under his eye. At the time of initial contact, the reporter states that the initial swelling on his face had improved but he did develop new swelling near his eye yesterday. The reporter was advised that the described symptoms are not expected with exposure to the product. Dermal exposure to the product may cause transient skin irritation but swelling is not typically seen unless the patient has an allergy either to this product or something else. The reporter was further advised to continue working with his doctor to determine a cause and appropriate treatment for his symptoms. The reporter could not be reached on follow-up. No further information is available.
Mineure